Pacific Edge surges; NZX 50 falls
Shares in cancer diagnostic firm Pacific Edge skyrocketed, climbing more than 20% on a deal with a large US insurer, even as the wider share market edged lower.
3 min read
3 min read
2 min read
3 min read
2 min read
2 min read
2 min read
3 min read
2 min read
3 min read
3 min read
3 min read
3 min read
2 min read
2 min read
BusinessDesk
Stories written by multiple reporters.
Followers will be emailed articles by BusinessDesk